Metagenomi (MGX) Return on Sales (2023 - 2025)
Historic Return on Sales for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to 2.36%.
- Metagenomi's Return on Sales fell 7200.0% to 2.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.87%, marking a year-over-year decrease of 15300.0%. This contributed to the annual value of 1.49% for FY2024, which is 300.0% up from last year.
- As of Q3 2025, Metagenomi's Return on Sales stood at 2.36%, which was down 7200.0% from 2.34% recorded in Q2 2025.
- Metagenomi's Return on Sales' 5-year high stood at 0.54% during Q2 2024, with a 5-year trough of 6.07% in Q1 2025.
- Over the past 3 years, Metagenomi's median Return on Sales value was 1.63% (recorded in 2024), while the average stood at 2.12%.
- Per our database at Business Quant, Metagenomi's Return on Sales soared by 6100bps in 2024 and then crashed by -38100bps in 2025.
- Quarter analysis of 3 years shows Metagenomi's Return on Sales stood at 1.56% in 2023, then crashed by -56bps to 2.43% in 2024, then rose by 3bps to 2.36% in 2025.
- Its last three reported values are 2.36% in Q3 2025, 2.34% for Q2 2025, and 6.07% during Q1 2025.